Global Absorbable Surgical Sutures Market to Reach USD 5.08 Billion by 2031 | CAGR of 6.7%
Category : Healthcare | Published Date : Nov 2024 | Type : Press Release
Absorbable Surgical Sutures Market Scope & Overview:
As per the Consegic Business Intelligence newly published report, the Absorbable Surgical Sutures Market was valued at USD 3.01 Billion in 2023 and is projected to reach USD 5.08 Billion by 2031, growing at a CAGR of 6.7% from 2024 to 2031. Absorbable surgical sutures are medical threads designed to dissolve naturally within the body, minimizing the need for suture removal post-surgery. Made from materials such as polyglycolic acid, polylactic acid, and catgut, these sutures are critical in surgeries requiring temporary internal tissue support during healing, particularly in gastrointestinal, gynecological, and orthopedic procedures.
The report comprises the Absorbable Surgical Sutures Market Share, Size & Industry Analysis, By Product Type (Monofilament Sutures, Multifilament Sutures), By Material (Synthetic Sutures, Natural Sutures), By Application (Cardiovascular Surgery, General Surgery, Orthopedic Surgery, Gynecological Surgery, Ophthalmic Surgery, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024-2031.
The report contains detailed information on Absorbable Surgical Sutures Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
The increasing volume of surgeries globally due to chronic diseases and an aging population is a significant driver of market growth. Additionally, advancements in synthetic and antimicrobial-coated sutures present opportunities for enhanced surgical outcomes.
Segmental Analysis :
Based on product type, the market is segmented into monofilament and multifilament sutures.
- Monofilament sutures held the largest share in 2023 due to their smooth structure, which minimizes tissue trauma and infection risks. They are widely used in delicate surgeries such as cardiovascular and ophthalmic procedures.
- Multifilament sutures are projected to grow rapidly, favored in procedures requiring high tensile strength and flexibility, such as orthopedic and general surgeries.
Based on material, the market is segmented into synthetic and natural sutures.
- Synthetic sutures dominated the market in 2023, preferred for their biocompatibility and predictable absorption rates. Materials like polyglycolic acid and polydioxanone offer superior wound support.
- Polydioxanone (PDO) is expected to witness the fastest growth due to its prolonged absorption time, suitable for surgeries requiring extended wound support.
Based on application, the market is segmented into cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, ophthalmic surgery, and others.
- Cardiovascular surgery held the largest market share, accounting for 35.18% in 2023, driven by the high demand for absorbable sutures to support temporary wound closure in cardiac procedures.
- Orthopedic surgery is anticipated to grow at the highest rate, with an increasing number of surgeries requiring sutures with high tensile strength for wound stabilization.
Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others.
- Hospitals accounted for the largest share in 2023, being the primary settings for a high volume of surgeries.
- Ambulatory surgical centers are projected to grow rapidly due to the rising trend of outpatient procedures that require absorbable sutures, minimizing follow-up visits.
Based on regions, the global market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
- Asia Pacific led the market in 2023, driven by the rise in surgeries and expanding healthcare infrastructure in countries like China and India.
- North America is expected to show significant growth due to a high volume of surgical procedures and advanced healthcare facilities.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 5.08 Billion |
| CAGR (2024-2031) | 6.7% |
| By Product Type | Monofilament Sutures, Multifilament Sutures |
| By Material | Synthetic Sutures, Natural Sutures |
| By Application | Cardiovascular Surgery, General Surgery, Orthopedic Surgery, Gynecological Surgery, Ophthalmic Surgery, Others |
| By End-User | Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers,
industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in
terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of
key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging
partnership trends and dynamics.
List of prominent players in the Absorbable Surgical Sutures Industry:
- Ethicon (Johnson & Johnson) (USA)
- Medtronic plc (Ireland)
- B. Braun Melsungen AG (Germany)
- Smith & Nephew plc (UK)
- Boston Scientific Corporation (USA)
- Teleflex Incorporated (USA)
- DemeTECH Corporation (USA)
- Internacional Farmacéutica (Mexico)
- Sutures India Pvt Ltd (India)
- Melsungen AG (Germany)
Recent Industry Developments :
- In April 2024, Samyang Holdings Corp. inaugurated a $22 million facility in Hungary to enhance its production capacity for biodegradable sutures, aiming to meet the rising European demand.
- In August 2023, Healthium Medtech launched TRUMAS, India's first specialized range of sutures for minimally invasive surgery, marking a milestone in localized medtech innovation.
